{"id":584749,"date":"2022-02-02T19:20:02","date_gmt":"2022-02-02T19:20:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=584749"},"modified":"2022-02-02T19:20:02","modified_gmt":"2022-02-02T19:20:02","slug":"postoperative-pain-management-pipeline-report-indepth-analysis-into-clinical-trials-emerging-drugs-treatment-outlook-key-players-vivozon-neumentum-menarini-acelrx-aft-pharma-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/postoperative-pain-management-pipeline-report-indepth-analysis-into-clinical-trials-emerging-drugs-treatment-outlook-key-players-vivozon-neumentum-menarini-acelrx-aft-pharma-others_584749.html","title":{"rendered":"Postoperative Pain Management Pipeline Report &#8211; In-depth Analysis into Clinical Trials, Emerging Drugs, &#038; Treatment Outlook | Key Players &#8211; Vivozon, Neumentum, Menarini, AcelRx, AFT Pharma, &#038; Others"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1585677425.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Postoperative Pain Management Pipeline Report - In-depth Analysis into Clinical Trials, Emerging Drugs, &amp; Treatment Outlook | Key Players - Vivozon, Neumentum, Menarini, AcelRx, AFT Pharma, &amp; Others\" src=\"https:\/\/www.abnewswire.com\/uploads\/1585677425.jpeg\" alt=\"Postoperative Pain Management Pipeline Report - In-depth Analysis into Clinical Trials, Emerging Drugs, &amp; Treatment Outlook | Key Players - Vivozon, Neumentum, Menarini, AcelRx, AFT Pharma, &amp; Others\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">\u201cPostoperative Pain Management Pipeline Insight, 2022&#8243; report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the Postoperative Pain Management Market.<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\">The <strong>Postoperative Pain Management Pipeline<\/strong> report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase.&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">The report also covers a detailed description of the drug including mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details.<\/p>\n<p style=\"text-align: justify;\"><img decoding=\"async\" style=\"display: block; margin-left: auto; margin-right: auto;\" title=\"Postoperative Pain Management Pipeline Analysis\" src=\"https:\/\/www.abnewswire.com\/uploads\/851e72fe6329fd711a11063b85ab79cc.jpg\" alt=\"Postoperative Pain Management Pipeline Analysis\" \/><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/postoperative-pain-management-pipeline-insights?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\"><strong>Postoperative Pain Management Pipeline Analysis<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>The report provides insights into:&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">The report provides detailed insights about companies that are developing therapies for the treatment of Postoperative Pain Management with aggregate therapies developed by each company for the same.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for the <strong>Postoperative Pain Management Treatment<\/strong>.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Postoperative Pain Management key companies<\/strong> involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Postoperative Pain Management Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the <strong>Postoperative Pain Management market<\/strong>.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">The report is built using data and information traced from the researcher&#8217;s proprietary databases, company\/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company\/university websites and industry-specific third-party sources, etc.&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Request for Sample Pages @&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/postoperative-pain-management-pipeline-insights?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\">Postoperative Pain Management Emerging Therapies and Key Companies<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/postoperative-pain-management-pipeline-insights?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\"><strong>Postoperative Pain Management Therapeutics Landscape<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><em>The current pipeline for postoperative pain holds many significant products being developed by some key players. The launch of the therapies is expected to change the health outcome in the coming years.<\/em><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Postoperative Pain Management Therapies covered in the market include:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Zalviso<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Maxigesic<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Dsuvia\/Dzuveo (Sufentanil)<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Dexketoprofen Tramadol<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">VVZ-149 Injections<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">IV Tramadol<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">TLC590 (ropivacaine with sustained-release delivery technology)<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">NTM-001<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">And many more&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Some of the key companies in the Postoperative Pain Management Market include:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Neumentum Pharmaceuticals<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Taiwan Liposome Company<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Avenue Therapeutics<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Vivozon<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Menarini Group<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">AFT Pharmaceuticals<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">AcelRx Pharmaceuticals<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">And many others<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Learn more about key companies &amp; emerging therapies, at &#8211;&nbsp;<\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/postoperative-pain-management-pipeline-insights?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\"><strong>https:\/\/www.delveinsight.com\/sample-request\/postoperative-pain-management-pipeline-insights<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Table of Content<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">1. Report Introduction<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">2. Postoperative Pain Management&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">3. Postoperative Pain Management Current Treatment Patterns<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">4. Postoperative Pain Management &#8211; DelveInsight&#8217;s Analytical Perspective<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">5. Therapeutic Assessment<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">6. Postoperative Pain Management Late Stage Products (Phase-III)<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">7. Postoperative Pain Management Mid Stage Products (Phase-II)<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">8. Early Stage Products (Phase-I)<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">9. Pre-clinical Products and Discovery Stage Products<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">10. Inactive Products<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">11. Dormant Products<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">12. Postoperative Pain Management Discontinued Products<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">13. Postoperative Pain Management Product Profiles<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">14. Postoperative Pain Management Key Companies<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">15. Postoperative Pain Management Key Products<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">16. Dormant and Discontinued Products<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">17. Postoperative Pain Management Unmet Needs<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">18. Postoperative Pain Management Future Perspectives<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">19. Postoperative Pain Management Analyst Review&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">20. Appendix<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">21. Report Methodology<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>*The table of contents is not exhaustive; the final content may vary.&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Visit to get the sample report:&nbsp;<strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/postoperative-pain-management-pipeline-insights?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\">https:\/\/www.delveinsight.com\/sample-request\/postoperative-pain-management-pipeline-insights<\/a><\/strong><br \/><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56421.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Shruti Thakur<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=postoperative-pain-management-pipeline-report-indepth-analysis-into-clinical-trials-emerging-drugs-treatment-outlook-key-players-vivozon-neumentum-menarini-acelrx-aft-pharma-others\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 09650213330<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=postoperative-pain-management-pipeline-report-indepth-analysis-into-clinical-trials-emerging-drugs-treatment-outlook-key-players-vivozon-neumentum-menarini-acelrx-aft-pharma-others\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Delveinsight Business Research LLP \u201cPostoperative Pain Management Pipeline Insight, 2022&#8243; report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the Postoperative Pain Management Market. The Postoperative Pain Management Pipeline report embraces in-depth commercial and &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/postoperative-pain-management-pipeline-report-indepth-analysis-into-clinical-trials-emerging-drugs-treatment-outlook-key-players-vivozon-neumentum-menarini-acelrx-aft-pharma-others_584749.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[435,405,406,403,404],"tags":[],"class_list":["post-584749","post","type-post","status-publish","format-standard","hentry","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/584749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=584749"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/584749\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=584749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=584749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=584749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}